316 related articles for article (PubMed ID: 22042278)
1. In silico engineering of L-asparaginase to have reduced glutaminase side activity for effective treatment of acute lymphoblastic leukemia.
Ln R; Doble M; Rekha VP; Pulicherla KK
J Pediatr Hematol Oncol; 2011 Dec; 33(8):617-21. PubMed ID: 22042278
[TBL] [Abstract][Full Text] [Related]
2. Engineering the substrate specificity of Escherichia coli asparaginase. II. Selective reduction of glutaminase activity by amino acid replacements at position 248.
Derst C; Henseling J; Röhm KH
Protein Sci; 2000 Oct; 9(10):2009-17. PubMed ID: 11106175
[TBL] [Abstract][Full Text] [Related]
3. Novel mutant of Escherichia coli asparaginase II to reduction of the glutaminase activity in treatment of acute lymphocytic leukemia by molecular dynamics simulations and QM-MM studies.
Ardalan N; Mirzaie S; Sepahi AA; Khavari-Nejad RA
Med Hypotheses; 2018 Mar; 112():7-17. PubMed ID: 29447943
[TBL] [Abstract][Full Text] [Related]
4. The glutaminase activity of L-asparaginase is not required for anticancer activity against ASNS-negative cells.
Chan WK; Lorenzi PL; Anishkin A; Purwaha P; Rogers DM; Sukharev S; Rempe SB; Weinstein JN
Blood; 2014 Jun; 123(23):3596-606. PubMed ID: 24659632
[TBL] [Abstract][Full Text] [Related]
5. L-Asparaginase as potent anti-leukemic agent and its significance of having reduced glutaminase side activity for better treatment of acute lymphoblastic leukaemia.
Ramya LN; Doble M; Rekha VP; Pulicherla KK
Appl Biochem Biotechnol; 2012 Aug; 167(8):2144-59. PubMed ID: 22684410
[TBL] [Abstract][Full Text] [Related]
6. Development of Escherichia coli asparaginase II for the Treatment of Acute Lymphocytic Leukemia: In Silico Reduction of asparaginase II Side Effects by a Novel Mutant (V27F).
Ardalan N; Akhavan Sepahi A; Khavari-Nejad RA
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1137-1147. PubMed ID: 33906306
[TBL] [Abstract][Full Text] [Related]
7.
Van Trimpont M; Schalk AM; De Visser Y; Nguyen HA; Reunes L; Vandemeulebroecke K; Peeters E; Su Y; Lee H; Lorenzi PL; Chan WK; Mondelaers V; De Moerloose B; Lammens T; Goossens S; Van Vlierberghe P; Lavie A
Haematologica; 2023 Feb; 108(2):409-419. PubMed ID: 35979719
[TBL] [Abstract][Full Text] [Related]
8. Selective reduction in glutaminase activity of l‑Asparaginase by asparagine 248 to serine mutation: A combined computational and experimental effort in blood cancer treatment.
Aghaeepoor M; Akbarzadeh A; Mirzaie S; Hadian A; Jamshidi Aval S; Dehnavi E
Int J Biol Macromol; 2018 Dec; 120(Pt B):2448-2457. PubMed ID: 30193917
[TBL] [Abstract][Full Text] [Related]
9. The differential ability of asparagine and glutamine in promoting the closed/active enzyme conformation rationalizes the Wolinella succinogenes L-asparaginase substrate specificity.
Nguyen HA; Durden DL; Lavie A
Sci Rep; 2017 Jan; 7():41643. PubMed ID: 28139703
[TBL] [Abstract][Full Text] [Related]
10. A Novel l-Asparaginase with low l-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias
Nguyen HA; Su Y; Zhang JY; Antanasijevic A; Caffrey M; Schalk AM; Liu L; Rondelli D; Oh A; Mahmud DL; Bosland MC; Kajdacsy-Balla A; Peirs S; Lammens T; Mondelaers V; De Moerloose B; Goossens S; Schlicht MJ; Kabirov KK; Lyubimov AV; Merrill BJ; Saunthararajah Y; Van Vlierberghe P; Lavie A
Cancer Res; 2018 Mar; 78(6):1549-1560. PubMed ID: 29343523
[TBL] [Abstract][Full Text] [Related]
11. Engineering reduced-immunogenicity enzymes for amino acid depletion therapy in cancer.
Cantor JR; Panayiotou V; Agnello G; Georgiou G; Stone EM
Methods Enzymol; 2012; 502():291-319. PubMed ID: 22208990
[TBL] [Abstract][Full Text] [Related]
12. Circumventing the side effects of L-asparaginase.
Fonseca MHG; Fiúza TDS; Morais SB; Souza TACB; Trevizani R
Biomed Pharmacother; 2021 Jul; 139():111616. PubMed ID: 33932739
[TBL] [Abstract][Full Text] [Related]
13. Glutaminase Activity of L-Asparaginase Contributes to Durable Preclinical Activity against Acute Lymphoblastic Leukemia.
Chan WK; Horvath TD; Tan L; Link T; Harutyunyan KG; Pontikos MA; Anishkin A; Du D; Martin LA; Yin E; Rempe SB; Sukharev S; Konopleva M; Weinstein JN; Lorenzi PL
Mol Cancer Ther; 2019 Sep; 18(9):1587-1592. PubMed ID: 31209181
[TBL] [Abstract][Full Text] [Related]
14. Efficient production of L-asparaginase from Bacillus licheniformis with low-glutaminase activity: optimization, scale up and acrylamide degradation studies.
Mahajan RV; Saran S; Kameswaran K; Kumar V; Saxena RK
Bioresour Technol; 2012 Dec; 125():11-6. PubMed ID: 23018158
[TBL] [Abstract][Full Text] [Related]
15. Dissecting dual specificity: Identifying key residues in L-asparaginase for enhanced acute lymphoid leukemia therapy and reduced adverse effects.
de Lima JY; de Castro Andreassa E; Venturi Biembengut Í; de Arruda Campos Brasil de Souza T
Int J Biol Macromol; 2024 Jan; 254(Pt 3):127998. PubMed ID: 37949271
[TBL] [Abstract][Full Text] [Related]
16. An isocratic fluorescence HPLC assay for the monitoring of l-asparaginase activity and l-asparagine depletion in children receiving E. colil-asparaginase for the treatment of acute lymphoblastic leukaemia.
Nath CE; Dallapozza L; Eslick AE; Misra A; Carr D; Earl JW
Biomed Chromatogr; 2009 Feb; 23(2):152-9. PubMed ID: 18823071
[TBL] [Abstract][Full Text] [Related]
17. L-asparaginase anti-tumor activity in pancreatic cancer is dependent on its glutaminase activity and resistance is mediated by glutamine synthetase.
Blachier J; Cleret A; Guerin N; Gil C; Fanjat JM; Tavernier F; Vidault L; Gallix F; Rama N; Rossignol R; Piedrahita D; Andrivon A; Châlons-Cottavoz M; Aguera K; Gay F; Horand F; Laperrousaz B
Exp Cell Res; 2023 May; 426(2):113568. PubMed ID: 36967104
[TBL] [Abstract][Full Text] [Related]
18. Structure of Helicobacter pylori L-asparaginase at 1.4 A resolution.
Dhavala P; Papageorgiou AC
Acta Crystallogr D Biol Crystallogr; 2009 Dec; 65(Pt 12):1253-61. PubMed ID: 19966411
[TBL] [Abstract][Full Text] [Related]
19. Structural and functional insights into Erwinia carotovora L-asparaginase.
Papageorgiou AC; Posypanova GA; Andersson CS; Sokolov NN; Krasotkina J
FEBS J; 2008 Sep; 275(17):4306-16. PubMed ID: 18647344
[TBL] [Abstract][Full Text] [Related]
20. Enhanced catalysis of L-asparaginase from Bacillus licheniformis by a rational redesign.
Sudhir AP; Agarwaal VV; Dave BR; Patel DH; Subramanian RB
Enzyme Microb Technol; 2016 May; 86():1-6. PubMed ID: 26992786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
